Panax notoginseng saponins promote endothelial progenitor cell mobilization and attenuate atherosclerotic lesions in apolipoprotein e knockout mice

Cellular Physiology and Biochemistry

Volumn 32, Issue 4, 2013, Pages 814-826

  Liu, Ya ^a   Hao, Fei ^a,b   Zhang, Haigang ^a   Cao, Dayan ^a   Lu, Xiaolan ^c   Li, Xiaohui ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Cadre Ward   (China)

^c AFFILIATED HOSPITAL OF NORTH SICHUAN MEDICAL COLLEGE   (China)

Author keywords

Atherosclerosis; Endothelial progenitor cell; Mobilization; Panax notoginseng saponins

Indexed keywords

APOLIPOPROTEIN E; CHEMOKINE RECEPTOR CXCR4; GELATINASE B; MESSENGER RNA; PANAX NOTOGINSENG SAPONIN; SAPONIN; STEM CELL ANTIGEN 1; STEM CELL FACTOR; STROMAL CELL DERIVED FACTOR 1ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2; GINSENOSIDE RB 1; GINSENOSIDE RG 1; NOTOGINSENOSIDE R1; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROTIC PLAQUE; BLOOD SAMPLING; BONE MARROW; CELL COUNT; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIAL PROGENITOR CELL; HISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; STEM CELL MOBILIZATION; TREATMENT DURATION; ATHEROSCLEROSIS; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BLOOD; CHINESE MEDICINE; CORONARY ARTERY DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; PANAX NOTOGINSENG; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STANDARDIZATION; STEM CELL; WESTERN BLOTTING;

MUS; PANAX NOTOGINSENG;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CELL MOVEMENT; ENDOTHELIAL CELLS; FLOW CYTOMETRY; MALE; MICE; MICE, KNOCKOUT; PANAX NOTOGINSENG; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SAPONINS; STEM CELLS;

EID: 84888149891     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000354484     Document Type: Article

References (45)

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Executive summary: heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013;127:143-152
2. Urbich C, Dimmeler S: Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004;95:343-353 (Pubitemid 39100452)
3. Young PP, Vaughan DE, Hatzopoulos AK: Biological properties of endothelial progenitor cells and their potential for cell therapy. Prog Cardiovasc Dis 2007;49:412-429
4. Werner N, Junk S, Laufs U, Link A, Walenta K, Bohm M, Nickenig G: Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 2003;93:e17-24
5. Griese DP, Ehsan A, Melo LG, Kong D, Zhang L, Mann MJ, Pratt RE, Mulligan RC, Dzau VJ: Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation 2003;108:2710-2715 (Pubitemid 37466815)
6. Hu Y, Davison F, Zhang Z, Xu Q: Endothelial replacement and angiogenesis in arteriosclerotic lesions of allografts are contributed by circulating progenitor cells. Circulation 2003;108:3122-3127 (Pubitemid 38031802)
7. Gan LJ, Zhang CH, Zhang M: Effect of intracoronary injection with xuesaitong in treating post-PCI slow-reflow phenomenon in patients with ST-segment elevation myocardial infarction. Zhongguo Zhong Xi Yi Jie He Za Zhi 2010;30:348-351
8. Liu X, Li J, Yang G, Wang J: Study on effect of promoting blood circulation drugs components in treating unstable angina in patients with blood stasis inflammatory levels. 2008;33:2950-2953
9. Liu Y, Zhang HG, Jia Y, Li XH: Panax notoginseng saponins attenuate atherogenesis accelerated by zymosan in rabbits. Biol Pharm Bull 2010;33:1324-1330
10. Fan JS, Liu DN, Huang G, Xu ZZ, Jia Y, Zhang HG, Li XH, He FT: Panax notoginseng saponins attenuate atherosclerosis via reciprocal regulation of lipid metabolism and inflammation by inducing liver X receptor alpha expression. J Ethnopharmacol 2012;142:732-738
11. Jia Y, Li ZY, Zhang HG, Li HB, Liu Y, Li XH: Panax notoginseng saponins decrease cholesterol ester via up-regulating ATP-binding cassette transporter A1 in foam cells. J Ethnopharmacol 2010;132:297-302
12. He CY, Li XH, Li SH, He XF: Protective effect of total Saponins of panax notognseng on vascular endothelial cell against injury induced by oxidized low density lipoprotein. China Pharmacy 2008;19:401-403
13. Zeng RH, Deng XM, Lu HX, Mo ZJ, Liu Y: Determination the contents of Panax Notoginseng Saponins in Compound Danshen Tablets by HPLC. Guide of China Medicine 2010;8:21-23
14. Xu Q, Wang J, He J, Zhou M, Adi J, Webster KA, Yu H: Impaired CXCR4 expression and cell engraftment of bone marrow-derived cells from aged atherogenic mice. Atherosclerosis 2011;219:92-99
15. Jackson KA, Majka SM, Wang H, Pocius J, Hartley CJ, Majesky MW, Entman ML, Michael LH, Hirschi KK, Goodell MA: Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2001;107:1395-1402. (Pubitemid 32522033)
16. Daniel JM, Bielenberg W, Stieger P, Weinert S, Tillmanns H, Sedding DG: Time-course analysis on the differentiation of bone marrow-derived progenitor cells into smooth muscle cells during neointima formation. Arterioscler Thromb Vasc Biol 2010;30:1890-1896
17. Gao D, Nolan DJ, Mellick AS, Bambino K, McDonnell K, Mittal V: Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 2008;319:195-198
18. Y Zhang YG, Zhang HG, Zhang GY, Fan JS, Li XH, Liu YH, Li SH, Lian XM, Tang Z: Panax notoginseng saponins attenuate atherosclerosis in rats by regulating the blood lipid profile and an anti-inflammatory action. Clin Exp Pharmacol Physiol 2008;35:1238-1244
19. Xu L, Liu JT, Liu N, Lu PP, Pang XM: Effects of Panax notoginseng saponins on proliferation and apoptosis of vascular smooth muscle cells. J Ethnopharmacol 2011;137:226-230
20. Leppnen O, Rutanen J, Hiltunen MO, Rissanen TT, Turunen MP, Sjblom T, Brggen J, Bckstrm G, Carlsson M, Buchdunger E, Bergqvist D, Alitalo K, Heldin CH, Ostman A, Yl-Herttuala S: Oral imatinib mesylate (STI571/gleevec) improves the efficacy of local intravascular vascular endothelial growth factor-C gene transfer in reducing neointimal growth in hypercholesterolemic rabbits. Circulation 2004;109:1140-1146 (Pubitemid 38332618)
21. Hillebrands JL, Klatter FA, van den Hurk BM, Popa ER, Nieuwenhuis P, Rozing J: Origin of neointimal endothelium and alpha-Actin-positive smooth muscle cells in transplant arteriosclerosis. J Clin Invest 2001;107:1411-1422 (Pubitemid 32522035)
22. Schmidt-Lucke C, Rssig L, Fichtlscherer S, Vasa M, Britten M, Kmper U, Dimmeler S, Zeiher AM: Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005;111:2981-2987 (Pubitemid 40814192)
23. Morishita T, Uzui H, Nakano A, Mitsuke Y, Geshi T, Ueda T, Lee JD: Number of endothelial progenitor cells in peripheral artery disease as a marker of severity and association with pentraxin-3, malondialdehyde-modified low-density lipoprotein and membrane type-1 matrix metalloproteinase. J Atheroscler Thromb 2012;19:149-158
24. Galasso G, De Rosa R, Ciccarelli M, Sorriento D, Del Giudice C, Strisciuglio T, De Biase C, Luciano R, Piccolo R, Pierri A, Di Gioia G, Prevete N, Trimarco B, Piscione F, Iaccarino G: ?2-Adrenergic Receptor Stimulation Improves Endothelial Progenitor Cell-Mediated Ischemic Neoangiogenesis. Circ Res 2013;112:1026-1034
25. Iwaguro H, Yamaguchi J, Kalka C, Murasawa S, Masuda H, Hayashi S, Silver M, Li T, Isner JM, Asahara T: Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 2002;105:732-738 (Pubitemid 34157378)
26. Schatteman GC, Hanlon HD, Jiao C, Dodds SG, Christy BA: Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest 2000;106:571-578 (Pubitemid 30666390)
27. Westenbrink BD, Lipsic E, van der Meer P, van der Harst P, Oeseburg H, Du Marchie Sarvaas GJ, Koster J, Voors AA, van Veldhuisen DJ, van Gilst WH, Schoemaker RG: Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization. Eur Heart J 2007;28:2018-2027 (Pubitemid 47579534)
28. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, Wang T, Gregg D, Ramaswami P, Pippen AM, Annex BH, Dong C, Taylor DA: Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 2003;108:457-463 (Pubitemid 36935540)
29. Miller-Kasprzak E, Jagodzi?ski PP: Endothelial progenitor cells as a new agent contributing to vascular repair. Arch Immunol Ther Exp (Warsz) 2007;55:247-259 (Pubitemid 47262710)
30. Zampetaki A, Kirton JP, Xu Q: Vascular repair by endothelial progenitor cells. Cardiovasc Res 2008;78:413-421 (Pubitemid 351769775)
31. Yin Y, Zhao X, Fang Y, Yu S, Zhao J, Song M, Huang L: SDF-1alpha involved in mobilization and recruitment of endothelial progenitor cells after arterial injury in mice. Cardiovasc Pathol 2010;19:218-227
32. Bogoslovsky T, Spatz M, Chaudhry A, Maric D, Luby M, Frank J, Warach S; NINDS Natural History of Stroke Investigators: Stromal-derived factor-1[alpha] correlates with circulating endothelial progenitor cells and with acute lesion volume in stroke patients. Stroke 2011;42:618-625
33. Walter DH, Haendeler J, Reinhold J, Rochwalsky U, Seeger F, Honold J, Hoffmann J, Urbich C, Lehmann R, Arenzana-Seisdesdos F, Aicher A, Heeschen C, Fichtlscherer S, Zeiher AM, Dimmeler S: Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ Res 2005;97:1142-1151
34. Dimmeler S: Regulation of bone marrow-derived vascular progenitor cell mobilization and maintenance. Arterioscler Thromb Vasc Biol 2010;30:1088-1093
35. Hattori K, Heissig B, Tashiro K, Honjo T, Tateno M, Shieh JH, Hackett NR, Quitoriano MS, Crystal RG, Rafii S, Moore MA: Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 2001;97:3354-3360
36. Xiao Q, Kiechl S, Patel S, Oberhollenzer F, Weger S, Mayr A, Metzler B, Reindl M, Hu Y, Willeit J, Xu Q: Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis-results from a large population-based study. PLoS One 2007;2:e975
37. De Falco E, Porcelli D, Torella AR, Straino S, Iachininoto MG, Orlandi A, Truffa S, Biglioli P, Napolitano M, Capogrossi MC, Pesce M: SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 2004;104:3472-3482 (Pubitemid 39564415)
38. Lamagna C, Bergers G: The bone marrow constitutes a reservoir of pericyte progenitors. J Leukoc Biol 2006;80:677-668
39. Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, Habler L, Ponomaryov T, Taichman RS, Arenzana-Seisdedos F, Fujii N, Sandbank J, Zipori D, Lapidot T: G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4 Nat Immunol 2002;3:687-694 (Pubitemid 34752479)
40. McQuibban GA, Butler GS, Gong JH, Bendall L, Power C, Clark-Lewis I, Overall CM: Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1 J Biol Chem 2001;276:43503-43508
41. Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, Giordano FJ: Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 2004;110:3300-3305 (Pubitemid 39557491)
42. Lvesque JP, Hendy J, Takamatsu Y, Simmons PJ, Bendall LJ: Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 2003;111:187-196 (Pubitemid 36105917)
43. Sen S, McDonald SP, Coates PT, Bonder CS: Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease. Clin Sci (Lond) 2011;120:263-283
44. Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR, Crystal RG, Besmer P, Lyden D, Moore MA, Werb Z, Rafii S: Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002;109:625-637 (Pubitemid 34628725)
45. Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver M, Murasawa S, Bosch-Marce M, Masuda H, Losordo DW, Isner JM, Asahara T: Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003;107:1322-1328. (Pubitemid 36314418)